Skip to main content
All lobbying filings

FOLEY & LARDNER LLP

Lobbying for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY · pharmaceutical manufacturing

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $70,000.00 income · posted Oct 20, 2025

Official filing document

 Lobbying activity 2
Pharmacy

Issues related to Domestic manufacturing; Issues related to 340B; implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill; Issues related to supply chain resilience; Issues related to tariffs; Issues related to 503B Compounding.

Health Issues

Issues related to Domestic manufacturing; Issues related to 340B; implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill; Issues related to supply chain resilience; Issues related to tariffs; Issues related to 503B Compounding.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem